'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease

20/08/2026

Neurology Today in 5

0:00

4:38

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about the impact of the "One Big Beautiful Bill Act" on neurology practice and research, how artificial intelligence is transforming the neurologist's workload, and the relationship between GBA1 mutations and Parkinson's disease.

Mais episódios de "Neurology Today in 5"

Wearable Devices, Thrombectomy Debate, Muscular Dystrophy Therapy
01/10/2026
4:28
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the pros and cons of wearable devices, new data for thrombectomy use in medium-vessel occlusion strokes, and a new treatment for limb-girdle muscular dystrophy type 2I/R9.
Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease
17/09/2026
5:02
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the first oral PCSK9 inhibitor, the transforming role of the neurology department chair, and anti-IgLON5 disease.
Não percas um episódio de “Neurology Today in 5” e subscrevê-lo na aplicação GetPodcast.
New Migraine Prevention Guidelines, Plasmapheresis for MOGAD Attacks, Benefits of Sabbaticals
03/09/2026
4:56
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about new migraine prevention guidelines, the use of plasmapheresis for acute MOGAD attacks, and how sabbaticals can help neurologists avoid burnout.
'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease
20/08/2026
4:38
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about the impact of the "One Big Beautiful Bill Act" on neurology practice and research, how artificial intelligence is transforming the neurologist's workload, and the relationship between GBA1 mutations and Parkinson's disease.
American Board of Psychiatry and Neurology Academic Pathway, EpiWatch App, Multiplexed MR Scanning
06/08/2026
5:05
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a pilot American Board of Psychiatry and Neurology Academic Pathway, a study of the EpiWatch app, and a new approach to magnetic resonance scanning.
Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence
16/07/2026
4:58
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.
OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology
02/07/2026
4:54
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.
Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation
18/06/2026
4:54
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation.
Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology
04/06/2026
4:54
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.
New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk
21/05/2026
4:32
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.

Mais episódios

Descobre o mundo dos podcasts com a app gratuita GetPodcast.

Subscreve os teus podcasts preferidos, ouve episódios offline e obtém recomendações fantásticas.

Política de privacidade
Ficha técnica
Portugal

Uma empresa de

'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease

Neurology Today in 5

Mais episódios de "Neurology Today in 5"

Wearable Devices, Thrombectomy Debate, Muscular Dystrophy Therapy

Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease

New Migraine Prevention Guidelines, Plasmapheresis for MOGAD Attacks, Benefits of Sabbaticals

'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease

American Board of Psychiatry and Neurology Academic Pathway, EpiWatch App, Multiplexed MR Scanning

Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology

Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation

Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology

New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk